Search Results 1141-1150 of 17823 for monoclonal antibody

  1. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. * Has had a prior anti-cancer monoclonal antibody (mAb), excluding anti ...

  2. A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma - Mayo Clinic

    Monoclonal antibodies within 28 days; Corticosteroid administration >20 mg/day of prednisone or equivalent within 14 days; Proteasome inhibitors within 14 ...

  3. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...

  4. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Allergies: History of severe allergic reactions to human or chimeric monoclonal antibodies, murine protein, or lenalidomide; Substance abuse: Drug or alcohol ...

  5. ABO incompatible kidney transplant - Mayo Clinic

    In the past, if your blood contained antibodies that reacted to your donor's blood type, the antibody reaction would immediately cause you to reject your ...

  6. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

    Had a prior anti-cancer monoclonal antibody (except immune CPI in the case of melanoma subjects) within 30 days prior to start of study treatment, or ...

  7. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

    ... monoclonal antibodies and glucocorticoids. Patients must be at least 90 days ... Patients who are hepatitis B core antibody positive, hepatitis B surface antigen ...

  8. A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue - Mayo Clinic

    History of allergic or anaphylactic reaction to any therapeutic or diagnostic monoclonal antibody. History of allergy or hypersensitivity to any of the ...

  9. Tebentafusp Regimen Versus Investigator's Choice In Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

    - previous severe hypersensitivity reaction to treatment with another monoclonal antibody (mAb) - active autoimmune disease requiring immunosuppressive ...

  10. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

    Participation eligibility · Chemotherapy < 21 days prior to first administration of study treatment and/or monoclonal antibody < 6 weeks prior to first ...